Posts by: Charles Moore

Charles Moore

Charles Moore has a long-proven track record in both print and digital journalism, touching on a wide range of subjects, from biotech and healthcare to politics and technology. He contributes substantial feature articles research and development for the news site, particularly pertaining to technology.

November 17, 2016

Biotech Focuses on Gene Therapy for Huntington’s, Heart Disease, Hemophilia B

News

Gene therapy biotech uniQure is prioritizing its drug pipeline to develop treatments for Huntington’s disease, hemophilia B, and its partnered gene therapy programs associated with uniQure’s collaboration with Bristol-Myers Squibb (BMS) in ... Read more

June 6, 2016June 7, 2016

Discovery Shows Enzyme May Protect Against Effects of Degenerative Brain Diseases

News

A multi-institutional study led by a team of biomedical researchers in the lab of Hui-Chen Lu at Indiana University at Bloomington, Indiana, has discovered evidence indicating that the enzyme nicotinamide mononucleotide adenylyl ... Read more

April 15, 2016April 15, 2016

Powerful Lumie Lights Donated to Huntington’s Disease Study at Cambridge University

News

Cambridge, England-based light therapy specialist Lumie will supply 24 of its most powerful light boxes, called Lumie Brazil, for use in a Huntington’s disease research study at the Cambridge School of Clinical ... Read more

January 25, 2016January 25, 2016

Huntington’s Gene-inducing Damage Might Have a Control Mechanism

News

Texas Tech University Health Sciences Center (TTUHSC) researchers have identified a molecule — mitochondrial division inhibitor 1 (Mdivi1) — believed to hold promise as a potential treatment for Huntington’s disease. Mitochondria ... Read more

December 18, 2015December 18, 2015

Neurinox Scientists Find Oxygen Radicals Play Dual Role in Neurodegenerative Diseases

News

Neurodegenerative diseases (ND) represent a major and growing healthcare problem, especially in developed nations with aging populations. These disorders affect mostly adults and can last for decades, causing long-term suffering ... Read more

November 16, 2015November 16, 2015

FDA Seeks Input on Huntington’s, Parkinson’s Disease Impact, Treatment

News

In 2013, the U.S. Food and Drug administration (FDA) selected Huntington’s disease (HD) and Parkinson’s disease (PD) as the focus of a three-year public consultation project for Patient-Focused Drug Development. ... Read more

November 13, 2015November 13, 2015

Medical Marijuana Access in NY Opens to Seriously Ill Huntington’s and Other Patients

News

Huntington’s disease is among a select group of disorders for which eligible patients can be prescribed medical marijuana in New York State. A bill signed this week by N.Y. Gov. Andrew M. Cuomo, passed by ... Read more

February 25, 2015February 26, 2015

University of Geneva Researchers Discover New Mitochondrial Activity Component Previously Undetected In Mammals

News

Mitochondria, the true energy power plants of cellular activity, play a vital role in energy production and in several other essential cellular processes, including lipid and amino acid metabolism, the ... Read more

February 16, 2015February 17, 2015

MitoAction hosts 4th Mitochondrial Disease Clinical Conference

News

As part of its ongoing effort to improve mitochondrial disease patient care, MitoAction — a nonprofit organization dedicated to improving the quality of life for children, adults, and families living with mitochondrial ... Read more

February 12, 2015February 12, 2015

Coenzyme Q10 Deficiency Linked To Rare Mitochondrial Disease Found Mainly In Children

News

A new international study by scientists at the University of Granada (UGR) in Spain, the University of Wisconsin-Madison, Columbia University in New York, and Rutgers, The State University of New ... Read more